Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1533 ARTÍCULOS , VIENDO DEL 1066 AL 1080

Practical considerations for choosing a mouse model of Alzheimer's disease

Jankowsky JL, Zheng H.

Mol Neurodegener. 2017 Dec 22;12(1):89. doi: 10.1186/s13024-017-0231-7.

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

Bos I, Verhey FR, Ramakers IHGB, Jacobs HIL, Soininen H, Freund-Levi Y, Hampel H, Tsolaki M, Wallin ÅK, van Buchem MA, Oleksik A, Verbeek MM, Olde Rikkert M, van der Flier WM, Scheltens P, Aalten P, Visser PJ, Vos SJB.

Alzheimers Res Ther. 2017 Dec 29;9(1):101. doi: 10.1186/s13195-017-0328-9.

Pain Assessment in Impaired Cognition (PAIC): content validity of the Dutch version of a new and universal tool to measure pain in dementia

van Dalen-Kok AH, Achterberg WP, Rijkmans WE, Tukker-van Vuuren SA, Delwel S, de Vet HC, Lobbezoo F, de Waal MW.

Clin Interv Aging. 2017 Dec 22;13:25-34. doi: 10.2147/CIA.S144651. eCollection 2018.

Understanding and Supporting Persons With Memory Loss and Their Families Across the Spectrum of Dementia

Gaugler JE.

J Appl Gerontol. 2017 Jul;36(7):779-781. doi: 10.1177/0733464817710755.

The Association between 5HT2A T102C and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease: A Meta-Analysis

Tang L, Wang Y, Chen Y, Chen L, Zheng S, Bao M, Xiang J, Luo H, Li J, Li Y.

Biomed Res Int. 2017;2017:5320135. doi: 10.1155/2017/5320135. Epub 2017 Nov 16.

Correlation study of Framingham risk score and vascular dementia: An observational study

Li SS, Zheng J, Mei B, Wang HY, Zheng M, Zheng K.

Medicine (Baltimore). 2017 Dec;96(50):e8387. doi: 10.1097/MD.0000000000008387.

The AAFP Cognitive Care Kit: A Resource for Family Physicians

Nebel KM, Loskutova NY.

Am Fam Physician. 2017 Nov 15;96(10):630-631.

Integrated Biomarkers for Depression in Alzheimer's Disease: A Critical Review

Wenzler S, Knochel C, Balaban C, Kraft D, Kopf J, Alves GS, Prvulovic D, Carvalho AF, Oertel-Knochel V.

Curr Alzheimer Res. 2017;14(4):441-452. doi: 10.2174/1567205013666160603011256.

Amyloid Imaging: Poised for Integration into Medical Practice

Anand K, Sabbagh M.

Neurotherapeutics. 2017 Jan;14(1):54-61. doi: 10.1007/s13311-016-0474-y.

Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team

Arnerić SP, Batrla-Utermann R, Beckett L, Bittner T, Blennow K, Carter L, Dean R, Engelborghs S, Genius J, Gordon MF, Hitchcock J, Kaplow J, Luthman J, Meibach R, Raunig D, Romero K, Samtani MN, Savage M, Shaw L, Stephenson D, Umek RM, Vanderstichele H, Willis B, Yule S.

J Alzheimers Dis. 2017;55(1):19-35. doi: 10.3233/JAD-160573.

Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors

Rivero-Santana A, Ferreira D, Perestelo-Pérez L, Westman E, Wahlund LO, Sarría A, Serrano-Aguilar P.

J Alzheimers Dis. 2017;55(2):625-644. doi: 10.3233/JAD-160366.

Biomarkers for the Early Detection and Progression of Alzheimer's Disease

Counts SE, Ikonomovic MD, Mercado N, Vega IE, Mufson EJ.

Neurotherapeutics. 2017 Jan;14(1):35-53. doi: 10.1007/s13311-016-0481-z.

Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress

Keshavan A, Heslegrave A, Zetterberg H, Schott JM.

Mol Diagn Ther. 2017 Feb;21(1):13-22. doi: 10.1007/s40291-016-0241-0.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias